As of 2026-03-31, the EV/EBITDA ratio of Moderna Inc (MRNA) is -6.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 17,087.96 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,561.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 13.4x | 10.2x |
| Forward P/E multiples | 9.5x - 12.6x | 12.5x |
| Fair Price | (57.55) - (76.61) | (68.64) |
| Upside | -219.3% - -258.8% | -242.3% |
| Date | EV/EBITDA |
| 2026-03-30 | -6.67 |
| 2026-03-27 | -6.88 |
| 2026-03-26 | -7.50 |
| 2026-03-25 | -7.49 |
| 2026-03-24 | -7.15 |
| 2026-03-23 | -7.14 |
| 2026-03-20 | -7.16 |
| 2026-03-19 | -7.31 |
| 2026-03-18 | -7.32 |
| 2026-03-17 | -7.55 |
| 2026-03-16 | -7.46 |
| 2026-03-13 | -7.34 |
| 2026-03-12 | -7.47 |
| 2026-03-11 | -7.87 |
| 2026-03-10 | -7.71 |
| 2026-03-09 | -7.83 |
| 2026-03-06 | -7.33 |
| 2026-03-05 | -7.54 |
| 2026-03-04 | -8.15 |
| 2026-03-03 | -6.92 |
| 2026-03-02 | -7.38 |
| 2026-02-27 | -7.50 |
| 2026-02-26 | -7.21 |
| 2026-02-25 | -7.16 |
| 2026-02-24 | -7.03 |
| 2026-02-23 | -6.99 |
| 2026-02-20 | -6.93 |
| 2026-02-19 | -6.90 |
| 2026-02-18 | -6.42 |
| 2026-02-17 | -6.01 |
| 2026-02-13 | -5.75 |
| 2026-02-12 | -5.42 |
| 2026-02-11 | -5.48 |
| 2026-02-10 | -5.71 |
| 2026-02-09 | -5.70 |
| 2026-02-06 | -5.56 |
| 2026-02-05 | -5.54 |
| 2026-02-04 | -5.83 |
| 2026-02-03 | -5.74 |
| 2026-02-02 | -5.80 |
| 2026-01-30 | -6.03 |
| 2026-01-29 | -6.46 |
| 2026-01-28 | -6.22 |
| 2026-01-27 | -6.24 |
| 2026-01-26 | -6.64 |
| 2026-01-23 | -6.75 |
| 2026-01-22 | -7.23 |
| 2026-01-21 | -6.92 |
| 2026-01-20 | -5.87 |
| 2026-01-16 | -5.69 |